Primary and Secondary Features of Parkinson's Disease Improve with Strategic Exposure to Bright Light: A Case Series Study
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
The antagonism of melatonin in models of Parkinson's disease (PD) can reduce the severity of motor impairment associated with dopamine (DA) degeneration. In consideration of the potent antidepressant effects of bright light therapy (LT), that LT suppresses melatonin secretion, that depression is commonly observed in PD, and that exposure to constant light facilitates recovery from experimental PD, the object of the present study was to strategically administer LT to PD patients and observe the effects on depression, insomnia, and motor performance. Twelve patients diagnosed with PD were exposed to white fluorescent light for 1-1.5 h at an intensity of 1000 to 1500 lux once daily commencing 1 h prior to the usual time of sleep onset, approximately 22:00 h in most patients. All patients were assessed before LT commenced and at two weeks, five weeks, and regular intervals thereafter. Within two weeks after commencing LT, marked improvement in bradykinaesia and rigidity was observed in most patients. Tremor was not affected by LT treatment; however, agitation, dyskinaesia, and psychiatric side effects were reduced, as verified by decreased requirement for DA replacement therapy. Elevated mood, improved sleep, decreased seborrhea, reduced impotence, and increased appetite were observed after LT. LT permitted the reduction of the dose of L-dopa, bromocriptine, or deprenyl in some patients by up to 50% without loss of symptom control. Factors limiting the efficacy of LT included multiple disease states, treatment compliance, polypharmacy, emotional stress, advanced age, and predominance of positive symptoms. The results of this case series study confirms previous work describing light as efficacious in the treatment of PD and suggest that controlled trials may help to elucidate how LT might be used strategically as an adjunct therapy to improve the morbidity of PD patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Light Suppresses Melatonin Secretion in Humans
Lewy, A. J., Wehr, T. A., Goodwin, F. K., Newsome, D. A., & Markey, S. P. (1980) · Science · doi:10.1126/science.7434030 · Cited by 1,913
Brainard, G. C., Lewy, A. J., Menaker, M., Fredrickson, R. H., Miller, L. S., Weleber, R. G., Cassone, V., & Hudson, D. (1988) · Brain Research · doi:10.1016/0006-8993(88)90820-7 · Cited by 233
Morning Light Treatment Hastens the Antidepressant Effect of Citalopram: A Placebo-Controlled Trial
Benedetti, F., Colombo, C., Pontiggia, A., Bernasconi, A., Florita, M., & Smeraldi, E. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0605 · Cited by 152 · cited 2×
“On this basis, and in collective consideration of reports suggesting the efficacy of LT in the treatment of SAD and nonSAD depression (Benedetti et al., 2003; Martiny, 2004; Rosenthal et al., 1984, 1988), that depression is commonly seen in PD (Deniker et al.”
MethodAdjunctive Bright Light in Non‐Seasonal Major Depression
Martiny, K. (2004) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2004.00460_2.x · Cited by 105
Effect of L-dopa on the seborrhoea of Parkinsonism
BURTON, J. L., CARTLIDGE, M., & SHUSTER, S. (1973) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1973.tb15453.x · Cited by 48 · cited 2×
“Clinically effective doses of L-dopa are known to decrease seborrhoea ( Burton et al., 1970, 1973 ), which can also be achieved by exposure to light (Maietta et al., 1991).”
Background
Cited by
'The clocks that time us'—circadian rhythms in neurodegenerative disorders
Videnovic, A., Lazar, A. S., Barker, R. A., & Overeem, S. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.206 · Cited by 373
Ethical and Methodological Standards for Laboratory and Medical Biological Rhythm Research
Portaluppi, F., Touitou, Y., & Smolensky, M. H. (2008) · Chronobiology International · doi:10.1080/07420520802544530 · Cited by 326
Pandi-Perumal, S. R., BaHammam, A. S., Brown, G. M., Spence, D. W., Bharti, V. K., Kaur, C., Hardeland, R., & Cardinali, D. P. (2013) · Neurotoxicity Research · doi:10.1007/s12640-012-9337-4 · Cited by 320
Hallucinations in Parkinson disease
Diederich, N. J., Fénelon, G., Stebbins, G., & Goetz, C. G. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.62 · Cited by 312
Videnovic, A., Klerman, E. B., Wang, W., Marconi, A., Kuhta, T., & Zee, P. C. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2016.5192 · Cited by 255
Metadata
- Authors
- Willis, G. L., & Turner, E. J. D.
- Venue
- Chronobiology International
- Publisher
- Informa UK Limited
- Published
- 2007-01
- Volume
- 24
- Issue
- 3
- Pages
- 521-537
- ISSN
- 0742-0528 (ISSN-L)
- 1525-6073
- OpenAlex
- W2155648393
- Cited by
- 143
- References
- 5
- FWCI
- 3.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Primary and Secondary Features of Parkinson's Disease Improve with Strategic Exposure to Bright Light: A Case Series Study. https://app.cochat.ai/papers/10.1080/07420520701420717
- The paper
- Willis, G. L., & Turner, E. J. D. (2007). Primary and Secondary Features of Parkinson's Disease Improve with Strategic Exposure to Bright Light: A Case Series Study. Chronobiology International. https://doi.org/10.1080/07420520701420717
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.